Maximilian von Eynatten

Maximilian von Eynatten is an accomplished professional in the field of clinical science and development, currently serving as Head Global Clinical Science at Aimmune Therapeutics since October 2020 and as Head Global Clinical Development at Nestlé Health Science since July 2019. Previously, Maximilian held the position of Global Head Medical Affairs for the Therapeutic Area of Cardio-Metabolism at Boehringer Ingelheim from June 2009 to June 2019. Earlier experience includes a role as a Faculty and Clinical Researcher in the Department of Medicine at Technical University Munich from October 2006 to May 2009.